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Since the precise mechanisms of posttraumatic stress disorder (PTSD) remain unknown, effective 
treatment interventions have not yet been established. Numerous clinical studies have led to the 
hypothesis that elevated glucocorticoid levels in response to extreme stress might trigger a 




To elucidate the pathophysiology of PTSD, we examined the alteration of hippocampal gene expression 




We measured nuclear GRs by western blot, and the binding of GR to the promoter of Bcl-2 and Bax 
genes by chromatin immunoprecipitation-qPCR as well as the expression of these 2 genes by RT-PCR in 




































































SPS-induced molecular, morphological, and behavioral alterations (hippocampal gene expression of 
Bcl-2 and Bax, hippocampal apoptosis using TUNEL staining, impaired fear memory extinction [FME] 
using the contextual fear conditioning paradigm).  
 
Results 
Exposure to SPS increased nuclear GR expression and GR binding to Bcl-2 gene, and decreased Bcl-2 
mRNA expression. Administration of GR antagonist immediately after SPS prevented activation of the 
glucocorticoid cascade, hippocampal apoptosis, and impairment FME in SPS rats.  
 
Conclusion 
The activation of GRs in response to severe stress may trigger the pathophysiological cascade leading to 
impaired FME and hippocampal apoptosis. In contrast, administration of GR antagonist could be useful 
for preventing the development of PTSD. 
 







































































Posttraumatic stress disorder (PTSD), the most widely prevalent stress-related mental disorder, is a 
tenacious, debilitating, and frequently intractable condition (Committee on the Assessment of Ongoing 
Efforts in the Treatment of Posttraumatic Stress et al. 2014). Although the precise mechanisms of PTSD 
are still unknown, dysfunction of the hypothalamo-pituitary-adrenal (HPA) axis is reported to be closely 
involved in the pathophysiology of PTSD. For example, Yehuda and colleagues demonstrated enhanced 
negative feedback of the HPA axis in response to dexamethasone in patients with PTSD (Daskalakis et al. 
2016; Szeszko et al. 2018; Yehuda et al. 2015), suggesting that HPA axis dysfunction may be due to 
increased levels of glucocorticoid receptor (GR) in the hippocampus. In addition, it has been reported that 
the measurement of GR mRNA in lymphocytes prior to traumatic stress exposure predicts incidence of 
PTSD (van Zuiden et al. 2012), and that lymphocyte GR levels and cytosine methylation levels at the 
promoter of the GR gene in the blood are increased in patients with PTSD (Yehuda et al., 2015). 
Similarly, to elucidate the mechanism responsible for the enhanced negative feedback of the HPA axis, 
Liberzon and coworkers showed that the transient down-regulation of GR mRNA levels (24 h after stress) 
and subsequent up-regulation of GR mRNA levels (7 days after stress) in the rat hippocampus were 
associated with enhanced negative feedback in the single prolonged stress (SPS) paradigm, an animal 
model of PTSD (Liberzon et al. 1999). In addition, it is well known that the activation of GRs alters gene 




































































element (GRE) at the promoter of various genes (Mifsud and Reul 2016; Necela and Cidlowski 2004; 
Oakley and Cidlowski 2013). Based on these findings, it is conceivable that elevated 
cortisol/corticosterone levels due to exposure to severe stress may be crucial to the development of the 
enhanced negative feedback of the HPA axis. In fact, according to the criteria of the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth edition (DSM-5), severe stressors must be a predisposing 
factor to the development of PTSD, and PTSD should be diagnosed more than 1 month after trauma. 
These criteria indicate that the activation of GRs and subsequent molecular changes are closely involved 
in the development of PTSD. Thus, to better understand the pathophysiology of PTSD, it is important to 
clarify the molecular changes that occur in the hippocampus subsequent to the elevation of 
glucocorticoids in response to stress. 
In line with dysfunction of the HPA axis, numerous clinical studies of PTSD have demonstrated 
functional and morphological abnormalities in the hippocampus after exposure to life-threating trauma 
(Szeszko et al. 2018), such as reduced hippocampal volume (Nelson and Tumpap 2017; O'Doherty et al. 
2015) and impaired fear memory extinction (Milad et al. 2008; Milad et al. 2009; Rothbaum and Davis 
2003). Additionally, changes in the expression of genes associated with the apoptotic pathway, such as 
imbalance of anti-apoptotic Bcl-2 and pro-apoptotic Bax, are reported to be involved in the mechanism of 
stress related to hippocampal atrophy (Gruver-Yates and Cidlowski 2013; Zhang et al. 2006). Although 




































































hippocampus through an imbalance of the Bcl-2/Bax ratio (Li et al. 2010b). These findings suggest that 
determining how SPS affects Bcl-2 and Bax gene expression through the activation of GR in the rat 
hippocampus would be helpful for elucidating the pathophysiology of PTSD in humans.  
With regard to the treatment of PTSD, combination treatment with selective serotonin reuptake 
inhibitors (SSRIs) and prolonged exposure therapy have been reported to be effective. However, 
approximately 30% to 40% of patients with PTSD remain chronically symptomatic and exhibit intrusion 
symptoms (Boe et al. 2010; Feuer et al. 2005; Friedman et al. 1995; Kessler et al. 1995; Schneier et al. 
2012). The effectiveness of psychosocial approaches (psychological debriefing (Litz et al. 2002; Mitchell 
1983) and cognitive behavioral therapy (Bryant et al. 1998; Bryant et al. 2005; Bryant et al. 1999; Foa et 
al. 2006)) and various pharmacological interventions (hydrocortisone (Schelling et al. 2001; Schelling et 
al. 2004), beta blockers (Pitman et al. 2002; Vaiva et al. 2003), SSRIs (Stoddard et al. 2011), morphine 
(Bryant et al. 2009; Holbrook et al. 2010), docosahexaenoic acid (Matsuoka et al. 2015), omega-3 
polyunsaturated fatty acids (Matsumura et al. 2017), and ketamine (McGhee et al. 2008)) has been 
investigated for preventing the development of PTSD at an earlier stage after traumatic stress exposure. 
Hydrocortisone has been regarded to be exceptionally effective in preventing PTSD based on moderate 
quality evidence from a 2014 Cochrane review (Amos et al. 2014) and the treatment guidelines of the 
International Society for Traumatic Stress Studies (https://www.istss.org/). Although the protective 




































































studies provided the evidence that a modest increase in glucocorticoid levels prior to acute stress exposure 
prevented the delayed enhancing effect of stress, such as synaptic connectivity in the basolateral 
amygdala and anxiety-like behavior (Karst et al. 2010; van Zuiden et al. 2012). However, the mechanism 
by which pharmacological therapies can facilitate extinction learning (Hruska et al. 2014) or enhance 
synaptic plasticity and connectivity (Zohar et al. 2011) remain hypothetical and the effectiveness of early 
clinical interventions has not yet been established (Qi et al. 2016). Thus, a better understanding of the 
underlying pathophysiology of PTSD could facilitate the development of novel strategies for the 
treatment and the prevention of the disorder.  
In the present study, we used the SPS paradigm as an animal model of PTSD. SPS mimics many aspects 
of the pathophysiological abnormalities associated with PTSD, and also some aspects of the associated 
behavioral characteristics (Souza et al. 2017; Yamamoto et al. 2009) including impaired fear memory 
extinction (Keller et al. 2015; Knox et al. 2012). We first examined the effect of SPS on nuclear levels of 
GRs in rat hippocampus by western blot. Next, we examined the binding of GR to the GRE at the 
promoters of the Bcl-2 and Bax genes by chromatin immunoprecipitation (ChIP)–qPCR, and we 
measured the expression of these 2 genes by RT-PCR in the hippocampus of rats after SPS. Lastly, we 
examined whether administration of a GR antagonist, GU486, immediately after SPS could prevent 
altered gene expression of Bcl-2 and Bax in the hippocampus, increase hippocampal apoptosis (measured 









































































































































Materials and methods 
All experimental procedures are shown in Fig. 1. 
Animals 
Male Sprague–Dawley rats weighing between 300 g and 350 g (Charles River Laboratories Japan, Inc., 
Yokohama, Japan) were used in this study. The animals were group-housed (3 per cage) and maintained 
on a 12-h light/dark cycle with food and water freely available. All procedures took place during the light 
cycle. All animal procedures were conducted in strict accordance with the Hiroshima University School 
of Medicine’s Animal Care Committee Guiding Principles on Animal Experimentations in Research 
Facilities for Laboratory Animal Science. 
 
Single Prolonged Stress (SPS) 
Animals were randomly assigned to either the sham or SPS group. During SPS treatment, sham rats 
were moved and placed in cages identical to those in which SPS was conducted. SPS was carried out in 3 
stages as previously described (Kataoka et al. 2018; Liberzon et al. 1997; Liberzon et al. 1999; 
Matsumoto et al. 2013): restraint for 2 h, forced swim for 20 min, and ether anesthesia. Briefly, each rat 
was restrained for 2 h by placing it inside a disposable clear polyethylene cone bag (Asahikasei, Tokyo, 
Japan) with only the tail protruding. After immobilization, they were individually placed in a clear acrylic 




































































forced to swim for 20 min. Following 15 min recuperation, they were exposed to diethyl ether until loss 
of consciousness. 
 
Measurement of the amount of nuclear glucocorticoid receptor (GR) in the hippocampus by 
western blotting 
We first examined whether SPS changed the nuclear levels of GRs in the rat hippocampus 1, 2, and 4 h 
(10 rats each) after SPS exposure (Fig. 1a). EpiQuik™ Nuclear Extraction Kit II (Epigentek, New York, 
NY, USA) was used for the preparation of nuclear proteins from hippocampal tissues according to the 
manufacturer’s instructions. The fidelity of the kit to isolate the nuclear extract of the rodent brain had 
been reported (Siuda et al. 2014; Wood et al. 2015). Total protein concentrations were measured using a 
BCA kit (Thermo Scientific, USA). Protein (30 µg) was loaded into each lane of 4% to 12 % gradient 
Bis–Tris SDS NuPAGE gels (Invitrogen, Carlsbad, CA, USA). Proteins were resolved by electrophoresis 
and blotted onto polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). The membranes 
were blocked at room temperature for 1 h in 1×TBS 1% Casein Blocker (Bio-Rad Laboratories, Tokyo, 
Japan), and then incubated overnight at 4°C with the primary antibodies diluted in 1×TBS 1% Casein 
Blocker. Antibodies used included those specific for GR (1:1000, catalogue number #3660; Cell 
Signaling Technology, Beverly, MA, USA), and TATA binding protein (1:1000, catalogue number #8515; 




































































antibodies (horseradish peroxidase-conjugated anti-rabbit IgG antibody; GE Healthcare, Little Chalfont, 
Buckinghamshire, UK) diluted 1:1000 with 1×TBS 1% Casein Blocker for 1 h at room temperature. The 
membranes were washed again and detected with the chemiluminescene ECL western blotting system 
(GE Healthcare). The densities of the immunoreactive bands were quantified with Image Lab software 
(Bio-Rad Laboratories). The GR value was corrected for the amount of TATA binding protein in each 
sample. 
 
Chromatin immunoprecipitation (ChIP) assay  
ChIP assays were performed to measure the extent of GR binding to the GRE at the Bcl-2 and Bax gene 
promoter sites using a ChIP kit (‘Epi Quik’, Epigentek) with some modifications (Fig. 1b). Whole 
hippocampus was minced into 1 mm-sized pieces and immediately crosslinked in 1% formaldehyde for 
20 min at room temperature. The crosslinking reaction was stopped by adding glycine. The tissue was 
washed and centrifuged at 800 rpm for 5 min. The pellet was then collected and homogenized in 
homogenizing buffer using a Dounce homogenizer (10-20 strokes). The homogenate was again 
centrifuged at 3000 rpm for 5 min. The supernatant was next lysed in lysis buffer containing protease 
inhibitor cocktail and the lysates were sonicated 10 times at 30-s intervals using a Bioruptor (Tosho 
Denki, Tokyo, Japan) at the maximum setting. Sonicated lysates were incubated with 300 U micrococcal 




































































bp in length. After the chromatin lysate was extracted and properly fragmented, chromatin lysates were 
diluted with ChIP dilution buffer. Aliquots (5 µL) of pre-immunoprecipitated diluted supernatant were 
saved as “input” DNA for later normalization. The chromatin solution was then immunoprecipitated at 
room temperature for 90 min with 5 μg of antibody directed against GR (catalogue number #12041, Cell 
Signaling Technology). The specificity of this antibody in ChIP assays has been previously established 
(Gao et al. 2015). As negative and positive controls, samples were immunoprecipitated with 1 μg 
nonimmune rabbit IgG and anti-RNA polymerase, respectively. Chromatin was then extracted and eluted 
from the columns with DNA release buffer containing protease K and elution buffer.  
 
Quantification of GR binding to GRE by real-time PCR  
GR binding to the GRE at the Bcl-2 and Bax gene promoter regions was quantified by measuring the 
amount of GR-immunoprecipitated DNA using quantitative real-time PCR with an ABI Prism 7900 
sequence detection system (PE Applied Biosystems). Specific primers and TaqMan MGB hybridization 
probes were designed and synthesized by Applied Biosystems to amplify the GRE of each gene explored 
using the EpiTect ChIP qPCR Primers transcription factors search tool from Qiagen (Qiagen EpiTect 
ChIP qPCR Primers Transcription Factor, SABiosciences.). The primers and probes used are shown in 
Table 1. The PCR assay for ‘input’ was performed for normalization at the same time. The PCR assay for 




































































construct a standard curve. The relative concentrations of genes in unknown samples were calculated 
from this standard curve, and the ratios of the relative concentrations of these genes were calculated 
relative to the concentration of ‘input’ DNA. 
 
Measurement of Bcl-2 and Bax mRNA levels in the hippocampus by real-time RT-PCR 
To determine the effects of SPS on the expression of apoptosis-associated genes in the hippocampus, we 
next performed RT-PCR to measure alterations in Bcl-2 and Bax mRNA levels (Fig. 1b). Total RNA was 
extracted from the hippocampus with an RNAqueous Phenol-free Total RNA Isolation kit (Ambion, 
Austin, TX, USA). Single-stranded cDNA was synthesized using the QuantiTect Reverse Transcription 
kit (Qiagen, Hilden, Germany). Levels of total Bcl-2 and Bax mRNA were determined by quantitative 
RT-PCR using the ABI Prism 7900 sequence detection system (PE Applied Biosystems). Specific primers 
and TaqMan probes were designed and synthesized by Applied Biosystems to amplify total cDNA of each 
gene. The primers and probes used are shown in Table 2. All samples were assayed in triplicate. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) quantification was performed using the TaqMan 
Rodent GAPDH Control Reagent kit (PE Applied Biosystems) as an internal control for normalization. 
The PCR assay for unknown samples was performed simultaneously with standard samples (rat 
hippocampus) to construct a standard curve. The relative concentrations of GAPDH and genes in 




































































were calculated relative to the concentration of GAPDH. 
 
TUNEL staining 
To detect apoptotic cells in the hippocampus, TdT-mediated dUTP nick end labeling (TUNEL) staining 
was performed using an In Situ Cell Death Detection kit, POD (Roche Diagnostic GmBH, Mannheim, 
Germany). One week after SPS, rats were deeply anesthetized with chloral hydrate (250 mg/kg, i.p.) and 
transcardially perfused with ice-cold PBS followed by 10% buffered formalin (Fig. 1b). Following 
perfusion, brains were removed and post-fixed in the same fixative for 24 h to 48 h at 4°C, cryoprotected 
in 30% sucrose-tris buffered saline (TBS) for 48 h to 72 h, and then sectioned at a thickness of 40 μm. 
The sections were made at approximately 3.8 mm (dorsal hippocampus [dHPC]) and 5.6 mm (ventral 
hippocampus [vHPC]) posterior to bregma (Paxinos and Watson 1998). The sections were incubated 
sequentially with paraformaldehyde for 10 min at room temperature, 0.6% TBST for 60 min at room 
temperature, proteinase K for 30 min at 37°C, 50 μL of TUNEL reaction mixture for 60 min at 37°C, and 
50 μL of converter-POD for 30 min at 37°C. Subsequently, sections were stained using a DAB Peroxidase 
Substrate Kit, ImmPACT (Vector Laboratories, Burlingame, USA), then counterstained with Methyl 
Green Solution (Fujifilm Wako Pure Chemical Industries, Osaka, Japan). Four microscopic fields per 
region in CA1, CA3, and the dentate gyrus (DG) were captured using a Keyence BZ-X800 fluorescence 




































































constant between sections. The ratio of apoptotic cells was determined as the number of TUNEL-positive 
cells divided by the total cell number (TUNEL-positive plus methyl green-positive cells). The Hybrid 
Cell Count algorithm for the Keyence BZ-X800 was used to assess TUNEL-positive and methyl 
green-positive cells. 
  
Fear conditioning test (FCT) 
Contextual fear conditioning, extinction training, and extinction test were performed as previously 
described (Kataoka et al. 2018) (Fig. 1c). On Day 7, rats were placed in a conditioning chamber (325 mm 
width, 280 mm height, 500 mm depth), and then were exposed to a 180-s conditioning context without 
any stimulation. Immediately after that, they received a 4-s, 0.8-mA footshock through a stainless steel 
grid floor by a shock generator-scrambler (SGS-003: Muromachi, Tokyo, Japan). Two footshocks were 
delivered with an inter-trial interval of 3 min. Following the footshocks, rats remained in the chamber for 
an additional 1 min before being returned to their home cages. Extinction training was defined as the 
repetitive exposure to the contextual cue (the chamber) in the absence of footshock. On Day 8, rats were 
placed for 10 min without footshock in the same chamber where the footshock was delivered. Extinction 
recall was tested on Day 9 under conditions identical to extinction training. 
Freezing time was monitored and a percentage score was calculated for the proportion of the total 




































































scored blindly by well-trained experimenters. 
 
Drug 
We used mifepristone (RU486) (TCI Chemicals, Tokyo, Japan) as a GR antagonist. RU486 antagonizes 
the function of GRs through 2 mechanisms; competition with corticosterone in the cytoplasm, and 
competition of the RU486-GR complex with corticosterone-GR complex in the nucleus for DNA binding 
(Peeters et al. 2008). RU486 (30 mg/kg body weight) was dissolved in dimethyl sulfoxide (Nacalai 
Tesque, Kyoto, Japan) and injected subcutaneously immediately after SPS. The dose and administration 
time of RU486 were decided according to previous studies using RU40555, an analogue of RU486 (Kim 
et al. 1998; Kohda et al. 2007). 
 
Statistical analysis 
All values shown represent mean ± SEM. The results of experiments containing 2 group of rats were 
analyzed by independent t-test (Experiment 1-2). The results of experiments containing 3 or 4 groups of 
rats were analyzed by one-way analysis of variance (ANOVA) followed by appropriate post hoc 
comparisons [Experiment 1-1, 1-3, 2-1, 2-2, 2-3 (fear conditioning)]. In experiment 2-3 (extinction 




































































measures (day) followed by appropriate post hoc comparisons. Results were considered statistically 







































































Experiment 1-1: The effect of SPS on nuclear GR levels in rat hippocampus  
We first examined the effect of SPS on the nuclear levels of GR in the rat hippocampus at 1, 2 and 4 
hours after SPS. Statistical analysis revealed significant effects of SPS on nuclear GR levels 
[F(3,35)=3.71, p<0.05]. Post hoc analysis revealed that whereas the nuclear GR level 2 h after SPS was 
significantly higher than in the sham group (p<0.05), there was no significant difference between SPS at 1 
h vs 2 h or at 2 h vs 4 h. There were no significant differences in nuclear GR levels among the 1 h 
post-SPS group, 4 h-post SPS, and sham groups (Fig. 2).  
 
Experiment 1-2: The effect of SPS on GR binding to the GRE of the Bcl-2 and Bax genes in rat 
hippocampus 
Since there was a significant increase in nuclear GR levels 2 h after SPS, we next performed ChIP-qPCR 
to examine GR binding to the GREs at the promoters of the Bcl-2 and Bax genes in the rat hippocampus 2 
h after SPS. Statistical analysis revealed that GR binding to the GRE of the Bcl-2 gene was significantly 
higher 2 h after SPS [t=2.01, df=35, p<0.05] (Fig. 3a). Conversely, GR binding to the GRE of the Bax 
gene did not differ significantly between the SPS and sham groups [t=2.05, df=28, p=0.49] (Fig. 3b).  
 




































































We next performed RT-PCR to examine the effects of SPS on Bcl-2 and Bax mRNA levels 2 h and 4 h 
after SPS. Statistical analysis revealed a significant effect of SPS on the levels of Bcl-2 mRNA [F(2,23)= 
6.19, p<0.01] (Fig. 4a) but not Bax mRNA [F(2,23)=2.59, p=0.10] (Fig. 4b). Post-hoc analysis revealed 
that the expression of Bcl-2 mRNA 2 h after SPS was significantly lower compared to the sham group 
(p<0.01), and there were no significant differences between the sham and the 4 h-post SPS groups or 
between the 2 h-post SPS and 4 h-post SPS groups (Fig. 4a).  
 
Experiment 2-1: Effect of RU486 on SPS-induced alteration of nuclear GR and Bcl-2 gene 
transcription in rat hippocampus 
We next examined the effect of a GR antagonist (RU486) on nuclear GR levels and the levels of Bcl-2 
and Bax mRNA 2 h after SPS. With respect to nuclear GR levels, statistical analysis revealed a significant 
main effect [F(2,55)=13.88, p<0.05], and post-hoc analysis indicated that nuclear GRs in the SPS group 
were significantly increased compared with the control group (p<0.05) and SPS + RU486 group (p<0.05). 
There was no significant difference between the control group and SPS + RU486 group (Fig. 5a). 
Statistical analysis also showed significant main effect on Bcl-2 [F(2,40)=5.18, p<0.05] but not Bax 
mRNA levels [F(2,40)=1.59, p=0.21] (Fig. 5b,c). Post-hoc analysis indicated that Bcl-2 mRNA levels 
were significantly decreased in the SPS group compared with the control (p<0.05) and SPS + RU486 




































































group (Fig. 5b).  
 
Experiment 2-2: Effect of RU486 on hippocampal apoptosis in SPS rats. 
We performed TUNEL staining of the dorsal and ventral portion of the hippocampus (dHPC and vHPC 
respectively). Statistical analysis revealed a significant main effect for the dHPC [F(2,53)=5.91, p<0.01], 
while post-hoc analysis revealed that TUNEL-positive cells in the SPS group were significantly increased 
compared with the control (p<0.05) and SPS + RU486 groups (p<0.01), and that there was no significant 
difference between the control and SPS + RU486 groups (Fig. 6a). Results for the vHPC were almost 
identical to those for the dHPC; statistical analysis revealed a significant main effect [F(2,49)=31.49, 
p<0.001], while post-hoc analysis indicated that hippocampal apoptosis in the SPS group was 
significantly increased compared with the control (p<0.01) and SPS + RU486 groups (p<0.01), and that 
there was no significant difference between the control and SPS + RU486 groups (Fig. 6b).  
 
Experiment 2-3: Effect of RU486 on impaired fear memory extinction in SPS rats. 
We next examined the effect of RU486 on impaired fear memory extinction in SPS rats. Fear memory 
extinction was evaluated using the FCT, and there were no significant differences in freezing during 
contextual fear conditioning between any groups (Fig. 7). Regarding fear memory extinction, statistical 




































































[F(2,110)=10.48, p<0.01]. There was no significant day x group interaction [F(2,110)=0.46, p=0.64]. Post 
hoc analysis revealed no significant differences in freezing time among any of the groups at the extinction 
training session. At the extinction test session, the freezing time of the SPS group was significantly longer 
compared with the control (p<0.05) and SPS + RU486 groups (p<0.05), and there was no significant 






































































The clinical findings from patients with PTSD, such as enhanced negative feedback of the HPA axis, 
smaller hippocampal volume, deficits in short-term verbal memory, and impaired fear extinction, have led 
to the hypothesis that elevated glucocorticoid levels in response to extreme stress trigger the 
pathophysiological cascade that ultimately leads to functional and morphological changes in the 
hippocampus. The results of the present study showed that activation of a GR-dependent nuclear cascade 
by SPS led to an increase in apoptotic cells and a diminished Bcl-2/Bax ratio in the rat hippocampus, 
whereas administration of RU486 immediately after SPS prevented these apoptotic changes in the 
hippocampus. Our findings support the involvement of hippocampal abnormalities due to extreme stress 
in the pathophysiology of PTSD. 
Although it is well established that exposure to extreme stress is the primary cause of PTSD, it has 
remained controversial as to whether elevation of glucocorticoids leads to the pathophysiology of PTSD 
(Szeszko et al. 2018). In this study, we first examined time-dependent changes in the nuclear GR levels in 
the hippocampus after SPS, and subsequently found that peak elevation of nuclear GRs occurred at 2 h 
after SPS. It has been reported that induction of nuclear translocation of GRs in the rat hippocampus by 
restraint stress is corticosterone-dependent and occur immediately after the administration of stress 
(Kitchener et al. 2004), and that plasma corticosterone levels are markedly increased following the 




































































transcription factor, it is conceivable that SPS may affect gene transcription in the rat hippocampus 
through an increase in nuclear GRs in response to increased blood corticosterone levels.  
To confirm the possibility that SPS alters gene transcription, we next examined GR binding to the GRE 
at the promoters of the Bcl-2 and Bax genes by measuring the respective mRNA levels in the rat 
hippocampus in response to SPS. We found that administration of SPS increased GR binding to the GRE 
of the Bcl-2 gene but not the Bax gene, and that Bcl-2 mRNA levels were decreased while the levels of 
Bax mRNA were unchanged. Nuclear GRs regulate gene expression by several modes of action, such as 
binding to GREs in target genes to activate gene transcription, binding to negative GREs (nGREs) at 
target genes to inhibit gene transcription, or interacting with other transcription factors (Necela and 
Cidlowski 2004; Oakley and Cidlowski 2013). Notably, the Bcl-2 gene contains nGRE at its promoter, 
and its expression is known to be decreased by glucocorticoid treatment (Mocetti et al. 2001; Surjit et al. 
2011). These findings further suggest that SPS decreases Bcl-2 gene transcription, but not that of the Bax 
gene, via activation of GR-dependent nuclear transduction, and consequently lead to a decreased 
Bcl-2/Bax ratio.  
With regard to the reduced Bcl-2/Bax ratio, we further examined whether SPS induced apoptosis in the 
hippocampus by TUNEL staining, and found an increase in apoptotic cells in the hippocampus of SPS 
rats. To our knowledge, there are 3 studies examining hippocampal apoptosis and changes in the levels of 




































































demonstrated hippocampal apoptosis in SPS rats, there were inconsistent results regarding the 
hippocampal levels of Bcl-2 and Bax. Results reported by Li and associates (Li et al. 2010b) were in good 
agreement with our findings; however, they reported upregulation of Bcl-2 and Bax immunoreactivity (Li 
et al. 2010a). Shafia and associates found increased levels of Bax mRNA with no change in the levels of 
Bcl-2 mRNA in the hippocampus of SPS rats ((Shafia et al. 2017). Although the reason for this 
discrepancy is unknown, the different experimental procedures, such as timepoints for measurement, or a 
difference between mRNA levels and immunoreactivity, may be associated.  
In the light of the demonstration of hippocampal apoptosis in SPS rats, it is noteworthy that some 
meta-analyses have indicated that individuals with PTSD have smaller hippocampal volume than both 
healthy volunteers and trauma-exposed individuals without PTSD (Nelson and Tumpap 2017; O'Doherty 
et al. 2015). In addition, the hippocampus is a highly heterogeneous structure and comprises functionally 
distinct sub-regions having different afferent and efferent connections (Fanselow and Dong 2010; 
Friedman et al. 2002), and the potential implication of sub-region specific abnormalities has been shown 
to be relevant to the symptoms of PTSD (Bonne et al. 2008; Keding and Herringa 2015). Together, our 
findings that SPS significantly increased apoptosis implicates a significant association between 
GR-dependent nuclear transduction activity and the diverse functional disturbances in PTSD.  
Notably, the transiently increased levels of nuclear GR, decreased levels of Bcl-2 mRNA, and increase 




































































antagonist RU486 immediately after SPS. Treatment with 30 mg/kg of RU486 immediately after SPS 
inhibited the activation of GR-dependent nuclear transduction by SPS, although RU486 at a dose of 20 
mg/kg was reported to act as a partial agonist (Spiga et al. 2011). Thus, in the present study, the ability of 
RU486 to prevent the decrease in Bcl-2 expression and increase in cellular apoptosis in response to SPS 
may be, at least in part, mediated by inhibition of the nuclear translocation of GRs.  
Since administration of RU486 immediately after SPS inhibited SPS-induced apoptotic signal 
transduction in the rat hippocampus, it is plausible that RU486 may have a preventive effect on impaired 
fear extinction in SPS rats. In fact, our study did find an inhibitory effect of this compound on impaired 
fear extinction in SPS rats. In line with the validity of SPS as an animal model of PTSD, a series of our 
studies and those by other researchers have demonstrated impaired fear extinction in SPS rats. In 
particular, the present study and a recent study by (Shafia et al. 2017) demonstrated both an increase in 
apoptotic cells in the vHPC and impaired fear extinction in SPS rats. It is well known that extinction is an 
active leaning process but that it does not erase the traumatic memory. In this context, it is likely that 
impaired extinction is due to impaired spatial leaning mediated by hippocampal apoptosis. However, 
since both (Shafia et al. 2017) and (Yamamoto et al. 2008) reported that there was no significant 
difference in freezing time 24 h after fear conditioning (the first day of extinction training) between SPS 
and sham rats, it is unlikely that the impaired spatial learning by hippocampal apoptosis is involved in the 




































































mRNA and protein in the hippocampus may be closely associated with impaired fear extinction in SPS 
rats. Collectively, it is plausible that not only GR-induced apoptosis but also decreased NR2B in the 
hippocampus may contribute to impaired fear extinction in SPS rats (Matsumoto et al. 2013). Since it has 
been recently suggested that impaired fear extinction is one of the hallmark symptoms of PTSD, further 
studies elucidating the precise mechanism of impaired fear extinction are necessary to develop an 
effective prevention strategy for PTSD.  
The efficacy of the glucocorticoid intervention on the prevention and treatment of PTSD is inconsistent 
across both human and animal studies. While administration of hydrocortisone is reported to be useful for 
the prevention of PTSD (Amos et al. 2014; Birur et al. 2017), GR antagonists and corticotropine-releasing 
factor type 1 antagonists are examined whether these drugs are effective in the treatment of PTSD 
(Dunlop et al. 2017; Golier et al. 2012). With regard to the preclinical studies, Rao and associates 
demonstrated that administration of corticosterone prior to restraint stress prevented the delayed increase 
in anxiety-like behavior (Rao et al. 2012). In addition, Keller and associates showed that administration of 
GR antagonist during extinction training exacerbated extinction retention deficits of SPS rats (Keller et al. 
2015). In contrast, Pitman and associates have shown that systemic mifepristone blocked the 
reconsolidation of cue-conditioned fear in contextual fear conditioning paradigm in rats (Pitman et al. 
2011). Based on these controversial findings, it is plausible that the relationship between the 




































































glucocorticoids on the development of PTSD. In particular, administration of GR antagonist prevented the 
increase in the nuclear GRs by SPS and alleviated the impaired fear extinction in SPS rats in this study. 
Although further studies are required, these evidences support the potential of hippocampal GR inhibition 
immediately after stress for prevention of the development of PTSD.  
With regard to fear memory extinction, it is well known that amygdala also plays an important role. 
Although we did not examine the nuclear GRs in the amygdala, it was reported that FC enhanced GR 
internalization and SPS attenuated the enhanced GR internalization in response to FC (Moulton et al. 
2018). In this context, further studies examining the nuclear GR in the amygdala of SPS rats are required 
to elucidate the involvement of GR-mediated signal on the development of impaired fear extinction.   
In summary, exposure to SPS increased GR nuclear translocation and subsequent GR binding to 
the GRE of the Bcl-2 gene, leading to a decrease in Bcl-2 mRNA levels without any change in Bax 
expression. Thus, an imbalance in apoptotic proteins (Bcl-2/Bax ratio) might lead to increased 
hippocampal apoptosis 1 week after SPS. Systemic administration of the GR antagonist RU486 
immediately after SPS prevented activation of the glucocorticoid cascade and hippocampal apoptosis in 
SPS rats. The preventive effect of RU486 on impaired fear memory extinction in SPS rats may be, at least 
in part, due to inhibition of hippocampal apoptosis. Based on these findings, we postulate that activation 
of hippocampal GRs in response to severe stress triggers the pathophysiological cascade that leads to 
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Fig. 1 Timelines for (a, b) biochemical and (c) behavioral tests.  
(a) Number signs 1-3 indicate the timepoints for hippocampal tissue sampling (#1, Nuclear GR, #2 
nuclear GR, chromatin immunoprecipitation, real-time RT-PCR, #3 nuclear GR, real-time RT-PCR) 
(b) Number signs indicate the timepoints for hippocampal tissue sampling (#1, nuclear GR, real-time 
RT-PCR, #2 TUNEL staining) 
(c) FC, fear conditioning; Ext Tr, extinction training; Ext Te, extinction test  
 
Fig. 2 Effect of SPS on nuclear translocation of GRs.  
Representative blots for GR and TATA binding protein (TBP) are shown in upper panel. Data are 
expressed as the ratio of expression of GR to that of TBP (GR/TBP) and shown as the mean ± SEM of the 
8 to 10 rats per group. Nuclear GR levels were significantly increased at 2 h after SPS. *p<0.05; one-way 
ANOVA with Tukey post-hoc analysis 
 
Fig. 3 Effect of SPS on GR binding to the GRE of (a) Bcl-2 gene and (b) Bax gene. 
Data are expressed as the ratio of target sequence (Bcl-2 or Bax) to that of input DNA (target 
sequence/input DNA) and shown as the mean ± SEM of 16 to 20 rats per group. (a) Binding to the GRE 




































































binding to the GRE of the Bax gene compared with the sham group. *p<0.05; independent t test 
 
Fig. 4 Effect of SPS on (a) Bcl-2 and (b) Bax mRNA expression. 
Data are expressed as the ratio of target gene (Bcl-2 or Bax) expression to that of GAPDH (target 
gene/GAPDH) and shown as the mean ± SEM of 8 to 10 rats per group. (a) Bcl-2 mRNA expression was 
significantly decreased 2 h after SPS. (b) There was no significant difference in Bax mRNA expression 
compared with the sham group. **p<0.01; one-way ANOVA with Tukey post-hoc analysis 
 
Fig. 5 Effects of RU486 on (a) GR nuclear translocation (b) Bcl-2 mRNA expression (c) Bax mRNA 
expression. 
(a) Representative blots for GR and TATA binding protein (TBP) are shown in the upper panel. Data are 
expressed as the ratio of GR expression to that of TBP (GR/TBP) and shown as the mean ± SEM of 19 to 
20 rats per group. Nuclear GR levels were significantly increased in the SPS group compared with the 
sham and SPS+RU486 groups. *p<0.05; one-way ANOVA with Tukey post-hoc analysis 
(b, c) Data are expressed as the ratio of target gene (Bcl-2 or Bax) expression to that of GAPDH (target 
gene/GAPDH) and shown as the mean ± SEM of 13 to 16 rats per group (b) Bcl-2 mRNA expression was 
significantly decreased in the SPS group compared with the sham group and SPS+RU486 group. (c) 






































































Fig. 6 Effect of RU486 on hippocampal apoptosis in SPS rats.  
Representative images of TUNEL staining in the hippocampus are shown in the upper panel. (a) dorsal 
hippocampus (dHPC), (b) ventral hippocampus (vHPC), Scale bar = 500 μm.  
Data are expressed as the ratio of TUNEL-positive cells to total cells (TUNEL-positive cells/total cells) 
and shown as the mean ± SEM of 16 to 20 sections per group (4 sections per rat). Hippocampal apoptosis 
in the SPS group was significantly increased compared with the sham and SPS+RU486 groups both in the 
(a) dHPC and (b) vHPC. *p<0.05, **p<0.01; one-way ANOVA with Tukey post-hoc analysis 
 
Fig. 7 Effect of RU486 on impaired fear memory extinction in SPS rats.  
Data are expressed as mean ± SEM of 16 to 21 rats per group. At the fear conditioning and extinction 
training session, there were no significant differences among the groups. At the extinction test session, the 
SPS group showed impaired fear memory extinction compared with the sham group, and the impaired 
fear memory extinction was inhibited by administration of RU486. *p<0.05; two-way ANOVA with 



































































Table 1. Primer and probe sequences used for real-time PCR (for quantification of GR-
immunoprecipitated DNA) 
 
Minor groove binder (MGB) is a Tm enhancer that increases sequence specificity.  





Forward primer 5’-TCCCTGAGCAAGTAGATGCAGTT-3’ 
Reverse primer 5’-TCTATTCAGAATGGAGGCTCTATCC-3’ 
TaqMan MGB probe 5’-CCTCGGCCGAGACT-3’ 
Bcl-2 associated 
X(Bax) 
Forward primer 5’-CTCGTAGGTCTCCGATAGTTCCTT-3’ 
Reverse primer 5’-AAGGAAACGGAGGCATCAGTAC-3’ 
TaqMan MGB probe 5’-CTCCAAATGGCCTGCAGA-3’ 
Table 1 Click here to access/download;Table;Table 1.docx







B-cell leukemia/lymphoma 2 (Bcl-2) NM 016993 Rn99999125_m1 
Bcl-2-associated X (Bax) NM 017059 Rn01480161_g1 
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